Oral Oncology
Volume 46, Issue 4 , Pages 276-282 , April 2010

Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan

  • Shyun-Yeu Liu

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Yongkang, Taiwan
    • Department of Medical Research, Chi-Mei Medical Center, Taiwan
  • ,
  • Chin-Li Lu

      Affiliations

    • Department of Medical Research, Chi-Mei Medical Center, Taiwan
  • ,
  • Chang-Ta Chiou

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Chang-Gung Memorial Hospital, Kaohsiung, Taiwan
  • ,
  • Ching-Yu Yen

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Yongkang, Taiwan
  • ,
  • Gwo-An Liaw

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Liouying, Taiwan
  • ,
  • Yi-Chun Chen

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
  • ,
  • Yu-Chi Liu

      Affiliations

    • Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan
  • ,
  • Wei-Fan Chiang

      Affiliations

    • Department of Medical Research, Chi-Mei Medical Center, Taiwan
    • Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Liouying, Taiwan
    • School of Dentistry, National Yang-Ming University, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Liouying. 201, Taikang Village, Liouying, Tainan 735, Taiwan. Tel.: +886 6 6226999x73158.

Received 8 December 2009 ,Revised 13 January 2010 ,Accepted 14 January 2010.

References 

  1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and areca-nut chewing and some areca-nutderived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004;85(1):11-18.
  2. Yang YH, Chen HR, Tseng CH, et al. Prevalence rates of areca/betel quid chewing in counties of Taiwan. Taiwan J Oral Med Health Sci. 2002;18(1):1–16
  3. Shiu MN, Chen TH. Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev. 2004;13(1):39–45
  4. Lee JJ, Jeng JH, Wang HM, Chang HH, Chiang CP, Kuo YS, et al. Univariate and multivariate analysis of prognostic significance of betel quid chewing in squamous cell carcinoma of buccal mucosa in Taiwan. J Surg Oncol. 2005;91(1):41–47
  5. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992;28(2–3):426–430
  6. Billroth T. Ein Gesamtbericht uber die chirurgische kliniken in Zurich und Wien wahrend der jahre 1870–1986. Erfahrungen auf dem gebiete der prakrischen chirurgie. Berlin: Hirschwald Inc.; 1879;p. 258
  7. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer. 1932;16:1358–1414
  8. Son YH, Kapp DS. Oral cavity and oropharyngeal cancer in a younger population. Cancer. 1985;55(2):441–444
  9. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck. 2002;24(2):165–180
  10. Yap SF, Ho PS, Kuo HC, Yang YH. Comparing factors affecting commencement and cessation of betel quid chewing behavior in Taiwanese adults. BMC Public Health. 2008;8:199–207
  11. Li SM, Rwei-Ling Y, Hu HC, Huang JS. Areca quid chewing by Taiwanese adolescents: application of the Attitudes Social Influence Self-efficacy (ASE) model. Addiction. 2003;98(12):1723–1729
  12. Moore C. Cigarette smoking and cancer of the mouth, pharynx, and larynx: a continuing study. JAMA. 1971;218(4):553–558
  13. Wynder EL, Dodo H, Bloch DA, Gantt RC, Moore OS. Epidemiologic investigation of multiple primary cancer of the upper alimentary and respiratory tracts, I: a retrospective study. Cancer. 1969;24(4):730–739
  14. Lo WL, Kao SY, Chi LY, Wong YK, Chang CS. Outcomes of oral squamous cell Carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg. 2003;61(7):751–758
  15. Ostrof JS, Jacobsen PB, Moadel AB, Spiro RH, Shah JP, Strong EW, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75(2):569–576
  16. Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope. 2005;115(4):629–639
  17. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990;66(1):109–113
  18. Boyle JO, Strong EW. Oral cavity cancer. In:  Shah JP editors. Cancer of the head and neck. Hamilton, Ontario, Canada: BC Decker; 2001;p. 100–126
  19. Yen CY, Lee SY, Hsieh JF, Wang DZ, Lin GN, Tsai CM, et al. Radiolocalized sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity and analysis of various parameters. Ann Surg Oncol. 2006;13(8):1130–1135
  20. Jones AS, Roland NJ, Field JK, Phillips DE. The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites. Clin Otolaryngol Allied Sci. 1994;19(1):63–69
  21. Byers RM, Clayman GL, McGill D, Andrews T, Kare RP, Roberts DB, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck. 1999;21(6):499–505
  22. Spiro JD, Spiro RH, Shah JP, Sessions RB, Strong EW. Critical assessment of supraomohyoid neck dissection. Am J Surg. 1988;156(4):286–289
  23. Medina JE, Byers RM. Supraomohyoid neck dissection: rationale, indications, and surgical technique. Head Neck. 1989;11(2):111–122
  24. Liaw GA, Yen CY, Chiang WF, Lee CH, Yang C, Chiou CT, et al. Outcome of treatment with total main tumor resection and supraomohyoid neck dissection in oral squamous cell carcinoma. J Formos Med Assoc. 2006;105(12):971–977
  25. Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck. 2005;27(12):1080–1091
  26. Kowalski LP, Bagietto R, Lara JR, Santos RL, Silva JF, Magrin J. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck. 2000;22(3):207–214
  27. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol. 2008;15(3):915–922
  28. de Visscher JG, Schaapveld M, Grond AJ, van der Waal I. Relationship of tumor thickness in punch biopsy and subsequent surgical specimens in stage I squamous cell carcinoma of the lower lip. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(2):141–144
  29. Shintani S, Yoshihama Y, Ueyama Y, Terakado N, Kamei S, Fijimoto Y, et al. The usefulness of intraoral ultrasonography in the evaluation of oral cancer. Int J Oral Maxillofac Surg. 2001;30(2):139–143
  30. Songra AK, Ng SY, Farthing P, Hutchison IL, Bradley PF. Observation of tumour thickness and resection margin at surgical excision of primary oral squamous cell carcinoma—assessment by ultrasound. Int J Oral Maxillofac Surg. 2006;35(4):324–331
  31. Lam P, Au-Yeung KM, Cheng PW, Wei WI, Yuen AP, Trendell-Smith N, et al. Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR Am J Roentgenol. 2004;182(3):803–808
  32. de Melo GM, Ribeiro KC, Kowalski LP, Deheinzelin D. Risk factors for postoperative complications in oral cancer and their prognostic implications. Arch Otolaryngol Head Neck Surg. 2001;127(7):828–833
  33. Kowalski LP, Alcantara PS, Magrin J, Parise O. A case control study on complications and survival in elderly patients undergoing major head and neck surgery. Am J Surg. 1994;168(5):485–490
  34. de Cássia Braga Ribeiro K, Kowalski LP. APACHE II, POSSUM, and ASA scores and the risk of perioperative complications in patients with oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 2003;129(7):739–745
  35. Penel N, Mallet Y, Roussel-Delvallez M, Lefebvre JL, Yazdanpanah Y. Factors determining length of the postoperative hospital stay after major head and neck cancer surgery. Oral Oncol. 2008;44(6):555–562
  36. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?. Cancer. 2008;112(1):94–103
  37. Arduino PG, Carrozzo M, Chiecchio A, Broccoletti R, Tirone F, Borra E, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg. 2008;66(8):1570–1579
  38. Koo BS, Lim YC, Lee JS, Choi EC. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol. 2006;42(10):789–794
  39. Liu SA, Wong YK, Lin JC, Poon CK, Tung KC, Tsai WC. Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse. Otolaryngol Head Neck Surg. 2007;136(1):112–118
  40. Rogers SN, Brown JS, Wooglar JA, Lowe D, Magennis P, Shaw RJ, et al. Survival following primary surgery for oral cancer. Oral Oncol. 2009;45(3):201–211
  41. Eckardt A, Barth EL, Kokemueller H, Wegener G. Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period. Oral Oncol. 2004;40(4):427–432
  42. Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck. 2000;22(1):34–41
  43. Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008;123(10):2390–2396
  44. Liao CT, Kang CJ, Chang JT, Wang HM, Ng SH, Hsueh C, et al. Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol. 2007;43(8):811–819
  45. Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck. 2002;24(2):198–206
  46. Nathanson A, Agren K, Biorklund A, Lind MG, Andréason L, Anniko M, et al. Evaluation of some prognostic factors in small squamous cell carcinoma of the mobile tongue: a multicenter study in Sweden. Head Neck. 1989;11(5):387–392
  47. Pearlman NW. Treatment outcome in recurrent head and neck cancer. Arch Surg. 1979;114(1):39–42

PII: S1368-8375(10)00020-5

doi: 10.1016/j.oraloncology.2010.01.008

Oral Oncology
Volume 46, Issue 4 , Pages 276-282 , April 2010